Parker Institute for Cancer Immunotherapy

The Parker Institute for Cancer Immunotherapy is dedicated to accelerating the development of breakthrough immune therapies, striving to transform all cancers into curable diseases. By breaking down entrenched infrastructure barriers that have historically slowed progress, the Parker Institute fosters groundbreaking new research and promotes an intellectual property model that encourages collaboration between researchers, nonprofits, and industry. The ultimate goal is to expedite the delivery of innovative treatments to patients.

Located at 1 Letterman Drive, D3500, San Francisco, CA 94129, US, the Parker Institute for Cancer Immunotherapy operates as a nonprofit organization committed to advancing the field of cancer immunotherapy. Through strategic partnerships and a focus on collaborative innovation, the Parker Institute is making significant strides in the fight against cancer. The organization's mission is fueled by a dedication to improving patient outcomes and transforming the landscape of cancer treatment.

The Parker Institute for Cancer Immunotherapy continues to expand its efforts, seeking new opportunities to drive progress and enhance its impact on the future of cancer care. The information will be completed soon with the support of the company’s management. We invite the manager of Parker Institute for Cancer Immunotherapy to create a customized and exclusive company showcase and product listing on our platform.